Method for treating intraocular neovascular diseases

Details for Australian Patent Application No. 2011101625 (hide)

International Classifications

Event Publications

22 December 2011 Innovation Patent Application Filed

19 January 2012 Innovation Patent Open to Public Inspection

Published as AU-B-2011101625

19 January 2012 Innovation Patent Sealed

16 February 2012 Certified Innovation Patents

Published as AU-B-2011101625

23 August 2012 Offer to Surrender

Genentech, Inc. 1 DNA Way , South San Francisco CA 94080-4990 , the Patentee of Letters Patent 2011101625 dated 22.12.2011 for an invention titled ' Method for treating intraocular neovascular diseases' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal.

18 October 2012 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.